Adrián Chapa‐Rodríguez
Role not yet determined Is this you? Add your title
Also affiliated: Louisiana State University (2017); Arkansas Children's Hospital (2022); Universidad Autónoma de Nuevo León (2008–2012); John H. Stroger, Jr. Hospital of Cook County (2014); Hospital Universitario Dr José Eleuterio Gonzalez (2008–2009); Cook County Health and Hospitals System (2014); University at Buffalo, State University of New York (2017); Louisiana State University Health Sciences Center Shreveport (2017–2018)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Research by Adrián Chapa‐Rodríguez focuses on the molecular mechanisms underlying non-alcoholic fatty liver disease (NAFLD). His work has investigated the role of SLAMF1, a protein expressed and secreted by hepatocytes, in mediating hepatocyte death within NAFLD models. Publications indicate that SLAMF1 expression in the liver and its plasma levels correlate with the severity of NAFLD in humans. Chapa‐Rodríguez's research also touches upon the transition of care for patients with eosinophilic gastrointestinal diseases, exploring associated challenges and opportunities. He has published 19 works with 872 citations and an h-index of 8.
Metrics
- h-index: 8
- Publications: 20
- Citations: 941
Selected Publications
-
Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities (2022)
-
SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis (2021)
Collaboration Network
Top Collaborators
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- SLAMF1 Mediates Hepatocyte Death in a Model of Non‐Alcoholic Steatohepatitis
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
- Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities
Similar Researchers
Based on overlapping research topics